Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug 27:11:1925.
doi: 10.3389/fimmu.2020.01925. eCollection 2020.

Commentary: Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis

Boning Zeng  1   2 , Rui Xing  3 , Changjiang Dong  4 , Feiyue Xing  1   2
Affiliations
Comment

Commentary: Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis

Boning Zeng et al. Front Immunol. .
No abstract available

Keywords: CXCL13; CXCR5; group 3 innate lymphoid cell; iBALT; mycobacterium tuberculosis; pulmonary tuberculosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Regulatory role of ILC3s in early pulmonary tuberculosis. ILC3s move from blood to lung, and recruit immune cells through the IL-17 and IL-22 to form iBALT structures in a CXCL13-CXCR5-dependent manner, exerting an early protective effect on Mtb infection. DC, dendritic cells; FDC, follicular dendritic cells; HEV, high endothelial venules; iBALT, inducible bronchus-associated lymphoid tissues.
See this image and copyright information in PMC

Comment on

  • Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis.
    Ardain A, Domingo-Gonzalez R, Das S, Kazer SW, Howard NC, Singh A, Ahmed M, Nhamoyebonde S, Rangel-Moreno J, Ogongo P, Lu L, Ramsuran D, de la Luz Garcia-Hernandez M, K Ulland T, Darby M, Park E, Karim F, Melocchi L, Madansein R, Dullabh KJ, Dunlap M, Marin-Agudelo N, Ebihara T, Ndung'u T, Kaushal D, Pym AS, Kolls JK, Steyn A, Zúñiga J, Horsnell W, Yokoyama WM, Shalek AK, Kløverpris HN, Colonna M, Leslie A, Khader SA. Ardain A, et al. Nature. 2019 Jun;570(7762):528-532. doi: 10.1038/s41586-019-1276-2. Epub 2019 Jun 5. Nature. 2019. PMID: 31168092 Free PMC article.

References

    1. Darrah PA, Zeppa JJ, Maiello P, Hackney JA, Wadsworth MHN, Hughes TK, et al. . Prevention of tuberculosis in macaques after intravenous BCG immunization. Nature. (2020) 577:95–102. 10.1038/s41586-019-1817-8 - DOI - PMC - PubMed
    1. Gupta N, Kumar R, Agrawal B. New players in immunity to tuberculosis: the host microbiome, lung epithelium, and innate immune cells. Front Immunol. (2018) 9:709. 10.3389/fimmu.2018.00709 - DOI - PMC - PubMed
    1. Abubakar I, Pimpin L, Ariti C, Beynon R, Mangtani P, Sterne JA, et al. . Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guerin vaccination against tuberculosis. Health Technol Assess. (2013) 17:1–372. 10.3310/hta17370 - DOI - PMC - PubMed
    1. Hunter R, Actor J. The pathogenesis of post-primary tuberculosis. A game changer for vaccine development. Tuberculosis (Edinb). (2019) 116S:S114–17. 10.1016/j.tube.2019.04.018 - DOI - PMC - PubMed
    1. Dheda K, Limberis JD, Pietersen E, Phelan J, Esmail A, Lesosky M, et al. . Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study. Lancet Resp Med. (2017) 5:269–81. 10.1016/S2213-2600(16)30433-7 - DOI - PubMed

Publication types